SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTX

NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Meridian Bioscience, Inc. VIVO's sale to SD Biosensor, Inc. and SJL Partners LLC for $34.00 per share in cash. If you are a Meridian shareholder, click here to learn more about your rights and options.

Hanger, Inc. HNGR's sale to Patient Square Capital for $18.75 in cash per share. If you are a Hanger shareholder, click here to learn more about your rights and options.

Silverback Therapeutics, Inc. SBTX's merger with ARS Pharmaceuticals, Inc. Under the terms of the merger agreement, assuming that Silverback's net cash at closing is $240 million, Silverback equity holders are expected to own approximately 37% of the combined company. If you are a Silverback shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  
https://www.halpersadeh.com